Drugs / Human Umbilical Cord-derived Mesenchymal Stem Cells

Trials 6 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT03219801 Aug 2017 → Dec 2018 systemic lupus erythematosus Hebei Medical University Unknown No outcome recorded
Phase 13 trials
Phase 1 NCT05984303 Aug 2023 → Aug 2024 cirrhosis of liver Beijing 302 Hospital Unknown No outcome recorded
Phase 1 NCT05227846 Mar 2022 → Jun 2024 cirrhosis of liver Beijing 302 Hospital Unknown No outcome recorded
Phase 1 NCT04996966 Aug 2021 → Dec 2023 ischemic disease, lung disorder Shanghai East Hospital Unknown No outcome recorded
Phase 1/21 trial
Phase 1/2 NCT02648386 Jan 2016 → Dec 2020 erectile dysfunction, rectal cancer Chinese Academy of Sciences Unknown No outcome recorded
Phase 21 trial
Phase 2 NCT04822922 Sep 2021 → Jul 2022 liver disorder Hai Li Unknown No outcome recorded

Evidence & citations 7 cited values

Every value below carries the sentence it was read from. 7 sources stand behind the page.

FieldValueCited text
Known as Human Umbilical Cord-derived Mesenchymal Stem Cells “The purpose of this study is to assess the safety and efficacy of autologous bone marrow mononuclear cells (BMMCs) or allogeneic human umbilical cord-derived mesenchymal stem...” NCT02648386
5

“In the treated group, 100-300 million allogeneic human umbilical cord derived mesenchymal stem cells were infused intravenously for one SLE patient.” NCT03219801

NCT05984303

NCT04996966

NCT04822922

NCT05227846

Known as hUC-MSCs “The purpose of this study is to assess the safety and efficacy of autologous bone marrow mononuclear cells (BMMCs) or allogeneic human umbilical cord-derived mesenchymal stem...” NCT02648386
1

“Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)” NCT04822922

Known as MSCs “In the MSCs injection group, 1×10\^6/kg human umbilical cord-derived mesenchymal stem cells were intravenously injected to the patient immediately after the surgery and at day...” NCT04996966
Known as UC-MSCs “This trial aims to explore the efficacy and safety of human umbilical cord-derived mesenchymal stem cells (UC-MSCs) for the treatment of patients with decompensated liver cirrhosis.” PMID 38159943 Dec 2023
Known as umbilical cord mesenchymal stem cells umbilical cord mesenchymal stem cells (UC-MSC)” NCT04822922
Modality Cell therapy “autologous bone marrow mononuclear cells (BMMCs) or allogeneic human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) combined with NeuroRegen scaffold transplantation” NCT02648386
Route Intravenous “were infused intravenously” NCT03219801